Science Explorer Interactive view Map
Company · Slough · United Kingdom

UCB Pharma (United Kingdom)

In research, UCB Pharma (United Kingdom) stands highest in Life Sciences (#2,959 of 14,347 worldwide), Medicine (#6,142 of 17,978 worldwide) and Health Sciences (#7,352 of 20,462 worldwide), over all time.

ucbpharma.co.uk/homeROR OpenAlex
World rank, 2022–2025
#12,046
of 28,054 · #7,083 all time
Rank in United Kingdom
#440
of 1,094
Research works
722
▲ 5% vs 2013–17
Citations
31k
42.6 per fractional work
Top-10% rate
17.2%
record average 16.5%
Open access
47%
world 28%

What is UCB Pharma (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #2,959 of 14,347 23.2%327
MedicineField #6,142 of 17,978 26.5%263
Health SciencesDomain #7,352 of 20,462 26.8%273
Biochemistry, Genetics and Molecular BiologyField #4,156 of 7,814 24.8%211
Molecular BiologySubfield #2,849 of 4,961 23.4%155

Each strip is that field’s whole ranked pool, with the notch where UCB Pharma (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.60× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 11.74× its world share, 13 worksImmunology and Micro…Neuroscience: 1.27× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.47× its world share, 2 worksPharmacology, Toxico…Chemistry: 1.43× its world share, 2 worksChemistryComputer Science: 0.16× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.99× its world share, 2 worksEarth and Planetary …Energy: 0.08× its world share, 0 worksEnergyEngineering: 0.22× its world share, 4 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceMathematics: 1.67× its world share, 2 worksMathematicsPhysics and Astronomy: 0.05× its world share, 0 worksPhysics and AstronomyDentistry: 0.70× its world share, 0 worksDentistryHealth Professions: 0.33× its world share, 1 worksHealth ProfessionsMedicine: 2.63× its world share, 54 worksMedicineNursing: 0.21× its world share, 0 worksNursingVeterinary: 0.38× its world share, 0 worksVeterinaryArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.05× its world share, 0 worksBusiness, Management…Decision Sciences: 0.78× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.31× its world share, 5 worksEconomics, Econometr…Social Sciences: 0.13× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.7×. Every wedge is a field page.

Who are the top researchers at UCB Pharma (United Kingdom)?

Ranked on the composite score, Barbara Ink lead among researchers whose main affiliation is UCB Pharma (United Kingdom).

  1. 1 Barbara Ink United Kingdom · #1,187,899 worldwide 25 citations · 20 works
All ranked researchers at UCB Pharma (United Kingdom)

Which keywords describe research at UCB Pharma (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, TGF-ß, Regulatory T Cells, Immune System, Inflammation, IL-17, TH17 Cells and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Autoantibodies10▲ 42×8 topics
  2. Inflammation10▲ 4.3×28 topics
  3. Epidemiology9▲ 2.1×30 topics
  4. Regulatory T Cells8▲ 66×4 topics
  5. TGF-ß8▲ 50×4 topics
  6. Immune System8▲ 30×3 topics
  7. Quality of Life8▲ 4.9×9 topics
  8. IL-177▲ 184×1 topic
  9. TH17 Cells7▲ 184×1 topic
  10. Monoclonal Antibodies6▲ 64×3 topics
  11. Immunotherapy5▲ 6.6×8 topics
  12. Prognosis5▲ 14×4 topics
  13. Ankylosing Spondylitis5▲ 162×1 topic
  14. Cancer5▲ 3.3×19 topics
  15. Glycosylation5▲ 41×3 topics
  16. Spondyloarthritis5▲ 162×1 topic
  17. Therapeutic Antibodies4▲ 61×2 topics
  18. Neurological Disorders4▲ 6.7×11 topics
  19. Neuromuscular Junction4▲ 93×2 topics
  20. Myasthenia Gravis4▲ 188×1 topic
  21. Thymic Tumors4▲ 188×1 topic
  22. Cytokines4▲ 13×4 topics
  23. Rheumatoid Arthritis4▲ 38×2 topics
  24. Biological Therapy4▲ 61×1 topic
  25. Cardiovascular Risk4▲ 11×2 topics
  26. Disease-Modifying Antirheumatic Drugs4▲ 69×1 topic
  27. Cost-effectiveness Analysis4▲ 40×1 topic
  28. Health Utility Measures4▲ 40×1 topic
  29. Antibody Engineering3▲ 57×1 topic
  30. Fc Receptors3▲ 57×1 topic
  31. Biomarkers3▲ 4.2×7 topics
  32. Immunosuppressive Therapy3▲ 16×6 topics
  33. Genetics3▲ 3.9×9 topics
  34. Biopharmaceuticals3▲ 52×3 topics
  35. Immunogenicity3▲ 61×2 topics
  36. Parkinson's Disease3▲ 11×6 topics
  37. Clinical Outcomes2▲ 9.1×2 topics
  38. Acne Inversa2▲ 190×1 topic
  39. Diagnostic Criteria2▲ 8.4×6 topics
  40. Genetic Susceptibility2▲ 20×2 topics

Which research topics does UCB Pharma (United Kingdom) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Myasthenia Gravis and Thymoma and Rheumatoid Arthritis Research and Therapies.

Psoriasis: Treatment and Pathogenesis: 7 fractional worksSpondyloarthritis Studies and Treatments: 5 fractional worksMyasthenia Gravis and Th…4Myasthenia Gravis and Thymoma: 4 fractional worksRheumatoid Arthritis Res…4Rheumatoid Arthritis Research and Therapies: 4 fractional worksHealth Systems, Economic…4Health Systems, Economic Evaluations, Quality of Life: 4 fractional worksMonoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksHidradenitis Suppurativa and Treatments: 2 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksSystemic Lupus Erythematosus Research: 1 fractional works
ImmunologyRheumatologyNeurologyEconomics and Econometrics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 7 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 5 works
  3. 3 Myasthenia Gravis and Thymoma Neurology 4 works
  4. 4 Rheumatoid Arthritis Research and Therapies Rheumatology 4 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  7. 7 Hidradenitis Suppurativa and Treatments Dermatology 2 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 2 works
  9. 9 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  10. 10 Systemic Lupus Erythematosus Research Rheumatology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.8%not open53.2%

World: 28% of research is openly available.

with international co-authors38.8%domestic only61.2%

World: 19% is written across borders.

How has UCB Pharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 5% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Slough

All research institutions in Slough

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.